Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2.
Luo Y, Li Z, Zhu H, Lu J, Lei Z, Su C, Liu F, Zhang H, Huang Q, Han S, Rao D, Wang T, Chen X, Cao H, Zhang Z, Huang W, Liang H.
Luo Y, et al. Among authors: huang q, huang w.
MedComm (2020). 2024 May 13;5(5):e535. doi: 10.1002/mco2.535. eCollection 2024 May.
MedComm (2020). 2024.
PMID: 38741887
Free PMC article.